| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
12 |
/ |
2020 |
|
|
|
| |
Data sporządzenia: |
2020-04-15 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Validation and Implementation of Quick Start to the CompuFlo Epidural System |
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_
today announced that it has validated the new “Quick Start," which has been implemented
into the CompuFlo® Epidural System. The Quick Start feature simplifies and provides
an alternative pathway to reduce the procedure preparation time for the CompuFlo®
instrument prior to the procedure.
Based on broad feedback from anesthesiologists, The Board of Directors of the Company
found it necessary to streamline the process for CompuFlo® in order to reduce the
procedure time for anesthesiologists. In addition, The Board of Directors of the Issuer
is exploring ways to make the use of our disposables more efficient, which the Company
looks forward to announcing in the future. Overall, the market feedback from both
anesthesiologists and hospitals has been encouraging and theIssuer looks forward to
providing the end users with future enhancements that they desire.
|
|
|
RB_ASO: Validation and Implementation of Quick Start to the CompuFlo Epidural System
